Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Qilu Tianhe Pharmaceutical, a core subsidiary of the Qilu Pharmaceutical Group, is a leading Chinese pharmaceutical manufacturer specializing in Active Pharmaceutical Ingredients (APIs) and finished dosage forms. The company is a global powerhouse in the production of anti-infective agents, particularly cephalosporins and penicillins, as well as oncology and cardiovascular medications. Operating out of Jinan, Shandong, its facilities are extensively certified by international regulatory bodies including the US FDA, European EDQM, and Japanese PMDA. Qilu Tianhe plays a vital role in the global supply chain, exporting high-quality generic medicines and providing contract manufacturing services to over 70 countries. The company is recognized for its large-scale fermentation and chemical synthesis capabilities, supporting both the domestic Chinese market and international healthcare systems.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Qilu Tianhe Pharmaceutical.